Literature DB >> 19369631

Myofibroblastic sarcoma vs nodular fasciitis: a comparative study of chromosomal imbalances.

Guo-Zhao Meng1, Hong-Ying Zhang, Zhang Zhang, Bing Wei, Hong Bu.   

Abstract

We investigated the molecular cytogenetic features in myofibroblastic sarcoma (MS) to gain insight into the nature of the controversial entity. DNA copy number changes were analyzed by comparative genomic hybridization in 29 cases of MS and 5 cases of nodular fasciitis. The characteristic chromosomal imbalances in MS were gains at 1p11 --> p36.3 (19/29 [66%]), 12p12.2 --> p13.2 (13/29 [45%]), 5p13.2 --> p15.3 (9/29 [31%]), and chromosome 22 (8/29 [28%]) and loss at 15q25 --> q26.2 (7/29 [24%]). In contrast, only 1 of 5 cases of nodular fasciitis showed genetic aberrations. The average number of aberrations in nodular fasciitis (0.4) was significantly lower than that in MS (5.4). Thus, MS displayed complex DNA copy number changes and shared no range of common chromosomal abnormality with nodular fasciitis, indicating that distinct genetic pathways may be involved in the development of these entities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19369631     DOI: 10.1309/AJCPV6H2WSYXLKFB

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  11 in total

1.  Updates on the cytogenetics and molecular cytogenetics of benign and intermediate soft tissue tumors.

Authors:  Jun Nishio
Journal:  Oncol Lett       Date:  2012-10-30       Impact factor: 2.967

Review 2.  Running GAGs: myxoid matrix in tumor pathology revisited: what's in it for the pathologist?

Authors:  Stefan M Willems; Malgorzata Wiweger; J Frans Graadt van Roggen; Pancras C W Hogendoorn
Journal:  Virchows Arch       Date:  2009-08-25       Impact factor: 4.064

3.  ARTEMIS stabilizes the genome and modulates proliferative responses in multipotent mesenchymal cells.

Authors:  Sarah A Maas; Nina M Donghia; Kathleen Tompkins; Oded Foreman; Kevin D Mills
Journal:  BMC Biol       Date:  2010-10-27       Impact factor: 7.431

Review 4.  In myofibroblastic sarcomas of the head and neck, mitotic activity and necrosis define grade: a case study and literature review.

Authors:  Chunyu Cai; Louis P Dehner; Samir K El-Mofty
Journal:  Virchows Arch       Date:  2013-10-17       Impact factor: 4.064

5.  Low-grade myofibroblastic sarcoma of the palate.

Authors:  Tomohiro Yamada; Tomohide Yoshimura; Naoya Kitamura; Eri Sasabe; Seiji Ohno; Tetsuya Yamamoto
Journal:  Int J Oral Sci       Date:  2012-08-31       Impact factor: 6.344

6.  Low-grade myofibroblastic sarcomas of the maxilla.

Authors:  Jin-Yu Qiu; Peng Liu; Ce Shi; Bing Han
Journal:  Oncol Lett       Date:  2014-12-11       Impact factor: 2.967

7.  Nodular Fasciitis of External Auditory Canal.

Authors:  Jihyun Ahn; Sunyoung Kim; Youngsil Park
Journal:  J Pathol Transl Med       Date:  2016-06-06

8.  Indolent growth of low-grade myofibroblastic sarcoma of the cheek mimics benign lesions: A case report and literature review.

Authors:  Tessho Maruyama; Toshiyuki Nakasone; Fumikazu Nimura; Akira Matayoshi; Toshihiro Kawano; Kazuhide Nishihara; Akira Arasaki
Journal:  Oncol Lett       Date:  2017-04-10       Impact factor: 2.967

9.  Nodular Fasciitis - Fine Needle Aspiration Cytology Diagnosis and Its Pitfalls, with Review of Literature.

Authors:  Padmapriya Jaiprakash; Balaji Radhakrishnan; Ranjini Kudva; Manna Valiathan; Seetharam Prasad
Journal:  Iran J Pathol       Date:  2018-12-27

10.  Low-Grade Myofibroblastic Sarcoma of the Oral Cavity: A Report of Three Cases Illustrating an Emerging Disease in Children.

Authors:  Primali Rukmal Jayasooriya; Chamara Athukorala; Manjula Attygalla; Balapuwaduge Ranjit Rigobert Nihal Mendis; Tommaso Lombardi
Journal:  Dermatopathology (Basel)       Date:  2021-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.